Smead Capital Management, Inc. Pfizer Inc Transaction History

Smead Capital Management, Inc.

$6.82 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $1.44 Million - $1.68 Million	-44,911 Reduced 3.11%	1,397,536 $46.4 Million
Q2 2023 Aug 11, 2023	SELL	$36.12 - $41.79 $794,351 - $919,045	-21,992 Reduced 1.5%	1,442,447 $52.9 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $1.55 Million - $2.01 Million	39,234 Added 2.75%	1,464,439 $59.7 Million
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $5.12 Million - $6.68 Million	122,577 Added 9.41%	1,425,205 $73.1 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $902,243 - $1.1 Million	20,618 Added 1.61%	1,302,628 $57 Million
Q2 2022 Aug 12, 2022	BUY	$46.53 - $55.17 $3.4 Million - $4.03 Million	73,062 Added 6.04%	1,282,010 $67.2 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $27.1 Million - $33.6 Million	-593,221 Reduced 32.92%	1,208,948 $62.6 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $13.1 Million - $19.4 Million	317,497 Added 21.38%	1,802,169 $106 Million
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $1.84 Million - $2.36 Million	46,804 Added 3.26%	1,484,672 $63.9 Million
Q2 2021 Jul 30, 2021	BUY	$35.91 - $40.68 $6.43 Million - $7.28 Million	178,965 Added 14.22%	1,437,868 $56.3 Million
Q1 2021 May 04, 2021	BUY	$33.49 - $37.77 $3.35 Million - $3.78 Million	99,969 Added 8.63%	1,258,903 $45.6 Million
Q4 2020 Feb 03, 2021	SELL	$33.47 - $42.56 $1.71 Million - $2.18 Million	-51,146 Reduced 4.23%	1,158,934 $42.7 Million
Q3 2020 Nov 04, 2020	SELL	$31.75 - $37.25 $4.12 Million - $4.84 Million	-129,873 Reduced 9.69%	1,210,080 $44.4 Million
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $3.58 Million - $4.34 Million	-118,771 Reduced 8.14%	1,339,953 $43.8 Million
Q1 2020 Apr 30, 2020	SELL	$27.03 - $38.62 $2.18 Million - $3.12 Million	-80,816 Reduced 5.25%	1,458,724 $47.6 Million
Q4 2019 Jan 30, 2020	BUY	$32.92 - $37.36 $844,825 - $958,769	25,663 Added 1.7%	1,539,540 $60.3 Million
Q3 2019 Oct 25, 2019	SELL	$32.49 - $42.13 $1.42 Million - $1.84 Million	-43,578 Reduced 2.8%	1,513,877 $54.4 Million
Q2 2019 Jul 26, 2019	SELL	$36.98 - $41.52 $1.86 Million - $2.09 Million	-50,217 Reduced 3.12%	1,557,455 $67.5 Million
Q1 2019 May 09, 2019	SELL	$37.5 - $41.2 $1.98 Million - $2.17 Million	-52,761 Reduced 3.18%	1,607,672 $68.3 Million
Q4 2018 Feb 04, 2019	SELL	$38.47 - $43.86 $3.11 Million - $3.55 Million	-80,882 Reduced 4.64%	1,660,433 $72.5 Million
Q3 2018 Oct 23, 2018	SELL	$34.47 - $41.81 $1.55 Million - $1.89 Million	-45,108 Reduced 2.53%	1,741,315 $76.7 Million
Q2 2018 Jul 24, 2018	SELL	$32.98 - $35.16 $1.07 Million - $1.14 Million	-32,298 Reduced 1.78%	1,786,423 $64.8 Million
Q1 2018 May 04, 2018	SELL	$31.91 - $37.02 $95,953 - $111,319	-3,007 Reduced 0.17%	1,818,721 $64.5 Million
Q4 2017 Feb 13, 2018	SELL	$33.26 - $35.29 $2.77 Million - $2.94 Million	-83,321 Reduced 4.37%	1,821,728 $66 Million
Q3 2017 Nov 06, 2017	BUY	$31.0 - $34.15 $59.1 Million - $65.1 Million	1,905,049	1,905,049 $68 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.8 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

290M
Shares

$7.77 Billion
0.35% of portfolio
Wellington Management Group LLP Boston, MA

164M
Shares

$4.38 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.48 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smead Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Smead Capital Management, Inc. with notifications on news.

Account